Hot Products
Catalog No. | Information |
CFN95033 | Gymnoside III Gymnoside III is a natural product from Gymnadenia conopsea. |
CFN95331 | Gynosaponin TN2 Gynosaponin TN-2 has anti-Parkinsonian activity. Gynosaponin TN-2 exerts protective effects on L-DOPA (100 and 200 μM)-induced apoptotic cell death by modulating extracellular signal-regulated protein kinases 1 and 2 activation in pheochromocytoma 12 cells. |
CFN93197 | Gypenoside A Reference standards. |
CFN91854 | Gypenoside L Gypenoside L inhibits autophagic flux and induces cell death in human esophageal cancer cells through endoplasm reticulum stress-mediated Ca2+ release. It also possesses non-small cell lung carcinoma A549 cell inhibitory activity. |
CFN91853 | Gypenoside LI Gypenoside LI possesses inhibitory effect on the growth of cancer cells, it induces G2/M arrest. |
CFN95239 | Gypenoside XIII Reference standards. |
CFN99717 | Gypenoside XLIX Gypenoside XLIX, a naturally occurring gynosaponin, inhibits NF-kappaB activation via a PPAR-alpha-dependent pathway, it may treat inflammatory and cardiovascular diseases, including atherosclerosis. |
CFN93372 | Gypenoside XLVI Gypenoside XLVI shows strong cytotoxic activity against A549 cells, with the IC50 values of 52.63±8.31 ug/ml. |
CFN90193 | Gypenoside XVII Gypenoside XVII confers protection against Aβ25-35-induced neurotoxicity through estrogen receptor-dependent activation of PI3K/Akt pathways, inactivation of GSK-3β and activation of Nrf2/ARE/HO-1 pathways. Gypenoside XVII has protective effects to the cellular and rodent models of Alzheimer's disease by activating TFEB. |
CFN98919 | Gyrophoric acid Vulpinic and gyrophoric acids are known as ultraviolet filters for natural lichen populations, they can effectively prevent cytotoxic, apoptotic and cytoskeleton alterative activities of 2.5 J/cm(2) UVB in a dose-dependent manner, suggest that vulpinic and gyrophoric acids can be promising cosmetic ingredients to photo-protect human skin cells. Gyrophoric acid also has anti-proliferative/cytotoxic effect. |